Brief: Australian Clinical Labs Intends To Make Off-Market Takeover Offer To Acquire Healius

Australian Clinical Labs

19/03/2023 21:52

March 20 (Reuters) - Australian Clinical Labs Ltd
 ACL.AX :
    * ANNOUNCES ITS INTENTION TO MAKE AN OFF-MARKET TAKEOVER
OFFER TO
ACQUIRE HEALIUS LIMITED
    * OFFER WILL BE MADE BY WAY OF AN OFF-MARKET TAKEOVER OFFER
BY ACL
TO ACQUIRE ALL OF HEALIUS SHARES ON ISSUE
    * ACL'S OFFER IS 0.74 ACL SHARES FOR EVERY 1 HEALIUS SHARE
HELD
    * IF ACL SUCCESSFUL IN ACQUIRING ALL OF HEALIUS SHARES ON
ISSUE
UNDER OFFER, HEALIUS SHAREHOLDERS WILL HOLD ABOUT 68% OF ACL
    * ACL EXPECTS THAT ITS EBIT FOR FY23 WILL BE WITHIN RANGE OF
A$68
MILLION AND A$74 MILLION
    * MATERIAL SYNERGY POTENTIAL OF A$95 MILLION BY BRINGING
COMPANIES
TOGETHER
    * POTENTIAL MERGED GROUP PRO FORMA FY23 EBIT OF A$361
MILLION
INCLUDING EXPECTED COST SYNERGIES


Further company coverage:  ACL.AX 

 ((reuters.briefs@thomsonreuters.com;))